Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 30, 2011
First-line bevacizumab-containing therapy for breast cancer: results in patients aged≥70 years treated in the ATHENA study
L Biganzoli, E Di Vincenzo, Z Jiang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2005
Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor
M Colleoni, S Li, R D Gelber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
G Gruber, B F Cole, M Castiglione-Gertsch, et al.
British Journal of Cancer
|
November 17, 2004
Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer
J Bernhard, D Zahrieh, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2009
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer
G Viale, A Giobbie-Hurder, B A Gusterson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2005
Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG
D Nitti, J Wils, J Guimaraes Dos Santos, et al.
British Journal of Cancer
|
June 28, 2002
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
M Colleoni, H J Litman, M Castiglione-Gertsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2004
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
G Berclaz, S Li, K N Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2000
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII
D Crivellari, M Bonetti, M Castiglione-Gertsch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
May 4, 2016
Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO)
A S Allal, C Ares, P Dulguerov, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 30, 2011
First-line bevacizumab-containing therapy for breast cancer: results in patients aged≥70 years treated in the ATHENA study
L Biganzoli, E Di Vincenzo, Z Jiang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2005
Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor
M Colleoni, S Li, R D Gelber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
G Gruber, B F Cole, M Castiglione-Gertsch, et al.
British Journal of Cancer
|
November 17, 2004
Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer
J Bernhard, D Zahrieh, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2009
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer
G Viale, A Giobbie-Hurder, B A Gusterson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2005
Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG
D Nitti, J Wils, J Guimaraes Dos Santos, et al.
British Journal of Cancer
|
June 28, 2002
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
M Colleoni, H J Litman, M Castiglione-Gertsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2004
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
G Berclaz, S Li, K N Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2000
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII
D Crivellari, M Bonetti, M Castiglione-Gertsch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
May 4, 2016
Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO)
A S Allal, C Ares, P Dulguerov, et al.
Page
of 9